4.5 Review

Epigenetic signatures in stem cells and cancer stem cells

期刊

EPIGENOMICS
卷 1, 期 2, 页码 261-280

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/EPI.09.19

关键词

cancer stem cells; chromatin modifications; DNA methylation; epigenetics; histone modifications; microRNAs; pluripotency; stemness

资金

  1. National Institutes of Health/National Cancer Institute (NIHINCI), United States
  2. Association pour la Recherche sur le Cancer (ARC), France
  3. la Ligue Nationale (Francaise) Contre le Cancer. France
  4. European Network of Excellence Environmental Cancer Risk, Nutrition and Individual Susceptibility (ECNIS)
  5. Agence Nationale de Recherhe Contre le Sida et Hepatites Virales (ANRS, France)
  6. Swiss Bridge Award

向作者/读者索取更多资源

The physiological properties of pluripotency in stem cells and the processes of cell specialization are governed by epigenetic mechanisms, as they are inheritable but not dependent on the cell genotype. There is cumulating evidence demonstrating the presence of cells with stem cell properties within tumors, suggesting that these cells are responsible for tumor growth and heterogeneity. As epigenetic control of self-renewal and pluripotency is a hallmark of stem cells, there is increased interest in studying similar epigenetic mechanisms governing these sternness properties in cancer stem cells. Here we will review the evidence supporting a role for epigenetic mechanisms in the induction of cancer stem cells, with an emphasis on the epigenetic regulatory networks involved in the establishment of normal self-renewal and pluripotency, and their potential deregulation in cancer. We will also discuss the data supporting the plasticity of these mechanisms and its potential therapeutic implications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据